Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Morning. Today, we see insurers telling Congress that hospital and drugmakers are to blame for health care pricing issues, and read about ways in which some drug shortages are easing.
Insurers fault others, including drugmakers, as D.C. scrutiny of pricing intensifies
Health insurance executives told Congress yesterday that they share lawmakers’ frustration with an overpriced, wasteful U.S. health care system. But they argued that the biggest drivers of rising costs are not insurers but others, particularly hospitals and drugmakers, STAT’s Bob Herman and Daniel Payne report.
Continue to STAT+ to read the full story…
STAT Pharma: The science and business of new drug development
Leave a Reply